About Zoetis Inc. (ZTS)
Zoetis Inc. is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector.
ZTS trades on the US stock exchanges (NYSE/NASDAQ) and is classified as a large-cap stock .
Key Statistics
- Current Price
- $79.72
- Market Cap
- $32.94B
- 52-Week High
- $144.83
- 52-Week Low
- $68.77
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
$1,000 Invested in Zoetis Inc. (ZTS)
How much would $1,000 invested in ZTS be worth today?
What would $1,000 invested in ZTS 1 year ago be worth today?
A $1,000 investment in Zoetis Inc. (ZTS) in 2025 would be worth $568 as of November 2026, representing a -43.2% total return.
What would $1,000 invested in ZTS 3 years ago be worth today?
A $1,000 investment in Zoetis Inc. (ZTS) in 2023 would be worth $529 as of November 2026, representing a -47.1% total return.
What would $1,000 invested in ZTS 5 years ago be worth today?
A $1,000 investment in Zoetis Inc. (ZTS) in 2021 would be worth $401 as of November 2026, representing a -59.9% total return.
What would $1,000 invested in ZTS 10 years ago be worth today?
A $1,000 investment in Zoetis Inc. (ZTS) in 2016 would be worth $1,720 as of November 2026, representing a +72.0% total return.
What would $1,000 invested in ZTS at IPO be worth today?
A $1,000 investment in Zoetis Inc. (ZTS) at IPO would be worth $2,907 as of November 2026, representing a +190.8% total return.
Monthly Returns Heatmap
Over the past 13+ years (164 months), Zoetis Inc. (ZTS) has averaged a monthly return of +0.85% with a median return of +1.10%. The stock had 99 positive months (60%) and 65 negative months (40%). The best month in ZTS's history was November 2014 with a +21.1% return, while the worst was May 2026 at -32.4%. Historically, November tends to be the strongest month (averaging +4.0%), and March the weakest (-2.0%).
ZTS's longest winning streak was 9 consecutive months of gains, while its longest losing streak was 6 consecutive months of losses. The best full year was 2019 with a cumulative return of +46.8%, and the worst was 2022 at -46.4%.
Annual Returns
Over 13 years of trading history, Zoetis Inc. (ZTS) has delivered an average annual return of +12.70% with a median return of +19.45%. The compound annual growth rate (CAGR) is +8.07%. The stock posted gains in 9 years (69%) and losses in 4 years (31%).
ZTS's best year was 2019 with a +55.71% gain, while the worst was 2022 at -39.51%. The longest streak of consecutive positive years was 8, and the longest losing streak was 3 years. ZTS achieved double-digit gains (10%+) in 9 years. It suffered double-digit losses in 4 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -35.21% | $123.05 | $79.72 |
| 2025 | -21.75% | $157.25 | $123.05 |
| 2024 | -16.63% | $188.62 | $157.25 |
| 2023 | +35.91% | $138.79 | $188.62 |
| 2022 | -39.51% | $229.42 | $138.79 |
| 2021 | +48.26% | $154.74 | $229.42 |
| 2020 | +25.76% | $123.04 | $154.74 |
| 2019 | +55.71% | $79.02 | $123.04 |
| 2018 | +19.45% | $66.15 | $79.02 |
| 2017 | +35.55% | $48.80 | $66.15 |
| 2016 | +12.64% | $43.33 | $48.80 |
| 2015 | +12.18% | $38.62 | $43.33 |
| 2014 | +32.80% | $29.08 | $38.62 |
Frequently Asked Questions: ZTS
What sector is ZTS in? ▼
ZTS operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has ZTS performed historically? ▼
Over 13 years of trading history, ZTS has posted gains in 9 years (69% of the time). The best year was 2019 with a +55.7% return. Past performance does not guarantee future results.
How can I invest in ZTS? ▼
You can invest in ZTS through any brokerage account that offers access to US stock exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold ZTS.
Last updated: 11/1/2026